PYC Therapeutics Statistics
Total Valuation
ASX:PYC has a market cap or net worth of AUD 688.68 million. The enterprise value is 640.90 million.
Market Cap | 688.68M |
Enterprise Value | 640.90M |
Important Dates
The last earnings date was Friday, February 28, 2025.
Earnings Date | Feb 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ASX:PYC has 550.95 million shares outstanding. The number of shares has increased by 25.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 550.95M |
Shares Change (YoY) | +25.01% |
Shares Change (QoQ) | +13.87% |
Owned by Insiders (%) | 37.97% |
Owned by Institutions (%) | 1.05% |
Float | 315.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.92 |
PB Ratio | 10.52 |
P/TBV Ratio | 13.38 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -13.30 |
EV / Sales | 25.65 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -12.94 |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.02.
Current Ratio | 5.46 |
Quick Ratio | 5.41 |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | -0.02 |
Interest Coverage | -1,225.33 |
Financial Efficiency
Return on equity (ROE) is -112.79% and return on invested capital (ROIC) is -71.07%.
Return on Equity (ROE) | -112.79% |
Return on Assets (ROA) | -58.01% |
Return on Invested Capital (ROIC) | -71.07% |
Return on Capital Employed (ROCE) | -88.15% |
Revenue Per Employee | 5.00M |
Profits Per Employee | -9.64M |
Employee Count | 5 |
Asset Turnover | 0.46 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.05% in the last 52 weeks. The beta is 0.65, so ASX:PYC's price volatility has been lower than the market average.
Beta (5Y) | 0.65 |
52-Week Price Change | +52.05% |
50-Day Moving Average | 1.22 |
200-Day Moving Average | 1.37 |
Relative Strength Index (RSI) | 50.37 |
Average Volume (20 Days) | 419,108 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:PYC had revenue of AUD 24.99 million and -48.20 million in losses. Loss per share was -0.11.
Revenue | 24.99M |
Gross Profit | 24.99M |
Operating Income | -50.11M |
Pretax Income | -48.72M |
Net Income | -48.20M |
EBITDA | -49.42M |
EBIT | -50.11M |
Loss Per Share | -0.11 |
Balance Sheet
The company has 49.25 million in cash and 1.21 million in debt, giving a net cash position of 48.04 million or 0.09 per share.
Cash & Cash Equivalents | 49.25M |
Total Debt | 1.21M |
Net Cash | 48.04M |
Net Cash Per Share | 0.09 |
Equity (Book Value) | 55.70M |
Book Value Per Share | 0.12 |
Working Capital | 50.75M |
Cash Flow
In the last 12 months, operating cash flow was -48.77 million and capital expenditures -780,060, giving a free cash flow of -49.55 million.
Operating Cash Flow | -48.77M |
Capital Expenditures | -780,060 |
Free Cash Flow | -49.55M |
FCF Per Share | -0.09 |
Margins
Gross margin is 100.00%, with operating and profit margins of -200.55% and -192.90%.
Gross Margin | 100.00% |
Operating Margin | -200.55% |
Pretax Margin | -194.96% |
Profit Margin | -192.90% |
EBITDA Margin | -197.75% |
EBIT Margin | -200.55% |
FCF Margin | n/a |
Dividends & Yields
ASX:PYC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -25.01% |
Shareholder Yield | -25.01% |
Earnings Yield | -7.00% |
FCF Yield | -7.19% |
Stock Splits
The last stock split was on November 15, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Nov 15, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
ASX:PYC has an Altman Z-Score of 21.34.
Altman Z-Score | 21.34 |
Piotroski F-Score | n/a |